Organigram Global Inc. (OGI), a cannabis company and the parent company of Organigram Inc. on Tuesday announced that James Yamanaka has been appointed as the new Chief Executive Officer with effect from around January 15, 2026.
Yamanaka is formerly Global Head of Strategy for British American Tobacco and will also join the Company's board of directors when he assumes the role of Chief Executive Officer.
Yamanaka brings more than 20 years at British American Tobacco and prior to joining the company, Yamanaka served as Area Director for North Asia.
Board chairman Peter Amirault has been appointed by the Board to serve as executive chair on an interim basis effective December 1 to oversee the day-to-day management of the Company until Yamanaka fully assumes the CEO role.
During this time, Geoff Machum, chair of the Board's Governance, Nominating and Sustainability Committee, will act as the independent lead director.
On Friday, Organigram closed trading 5.4054% higher at $1.5600 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.